Skip to main content
. 2019 Nov;7(22):619. doi: 10.21037/atm.2019.11.27

Table 1. Descriptive characteristics of the study patients.

Features All patients (n=12)
Mean ± SD/n Range/%
Patient characteristics
   Age, years 71.1±9.2 52–84
   Gender, male 10 83.3
   Smoker, yes 12 100.0
   Adenocarcinoma 9 75.0
   Squamous cell carcinoma 3 25.0
   Stage I 2 16.7
   Stage II 4 33.3
   Stage III 6 50.0
FACS analysis, %
   ALDH+ 4.6±3.8 0.7–12.5
   CD3+ 10.8±9.1 1.0–25.7
   CD4+ 5.3±5.7 0.2–18.6
   CD8+ 3.2±3.0 0.5–10.9
Immunohistochemistry by CD3, CD4, CD8 (15) (n=8)
   CD3+
      No or sporadic 1 12.5
      Moderate 6 75.0
      Abundant 1 12.5
   CD4+
      No or sporadic 2 25.0
      Moderate 5 62.5
      Abundant 1 12.5
   CD8+
      No or sporadic 4 50.0
      Moderate 4 50.0
      Abundant 0 0

SD, standard deviation; FACS, fluorescence-activated cell sorting.